Efficacy of Poly-Gamma-Glutamic Acid in Women with High-Risk Human Papillomavirus-Positive Vaginal Intraepithelial Neoplasia: an Observational Pilot Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Poly-gamma-glutamic acid (γ-PGA) is a natural polymer that is synthesized by Bacillus species and has been reported to have antitumor activity. The aim of this study was to investigate the effect of γ-PGA on the treatment of vaginal intraepithelial neoplasia (VAIN). A retrospective observational study on γ-PGA therapy for biopsy-proven VAIN was conducted. The efficacy was assessed by evaluating the results of Pap cytology and the viral load of high-risk HPV at three time points: at enrollment, and at the first and second post-treatment visits. Of 17 patients treated with γ-PGA, only 12 patients who had a high-risk HPV infection were included in the analysis. Histology was VAIN1 in seven patients, VAIN2 in two patients, and VAIN3 in three patients. γ-PGA was administered for newly diagnosed VAIN in five (41.7%) patients and persistent VAIN in seven (58.3%) patients for the mean time of 4.5 months. At the first and second post-treatment visits, cytological regression was observed in five (41.7%) and six (50%) patients, respectively. Regarding the HPV load, the overall response rate was 66.7%, and the mean level was 670.6 ± 292.5 RLU at the first follow-up, which was lower than the initial viral load of 1,494.8 ± 434.5 RLU (p = 0.084). At the second follow-up, the overall response rate was 58.3%, and the mean viral load level was 924.2 ± 493.7 RLU. γ-PGA may be helpful for the cytological regression and reduction of viral load in patients with high-risk HPV-positive VAIN, suggesting that γ-PGA is a promising treatment option for primary or persistent VAIN.
Abstract
Poly-gamma-glutamic acid (γ-PGA) is a natural polymer that is synthesized by Bacillus species and has been reported to have antitumor activity. The aim of this study was to investigate the effect of γ-PGA on the treatment of vaginal intraepithelial neoplasia (VAIN). A retrospective observational study on γ-PGA therapy for biopsy-proven VAIN was conducted. The efficacy was assessed by evaluating the results of Pap cytology and the viral load of high-risk HPV at three time points: at enrollment, and at the first and second post-treatment visits. Of 17 patients treated with γ-PGA, only 12 patients who had a high-risk HPV infection were included in the analysis. Histology was VAIN1 in seven patients, VAIN2 in two patients, and VAIN3 in three patients. γ-PGA was administered for newly diagnosed VAIN in five (41.7%) patients and persistent VAIN in seven (58.3%) patients for the mean time of 4.5 months. At the first and second post-treatment visits, cytological regression was observed in five (41.7%) and six (50%) patients, respectively. Regarding the HPV load, the overall response rate was 66.7%, and the mean level was 670.6 ± 292.5 RLU at the first follow-up, which was lower than the initial viral load of 1,494.8 ± 434.5 RLU (p = 0.084). At the second follow-up, the overall response rate was 58.3%, and the mean viral load level was 924.2 ± 493.7 RLU. γ-PGA may be helpful for the cytological regression and reduction of viral load in patients with high-risk HPV-positive VAIN, suggesting that γ-PGA is a promising treatment option for primary or persistent VAIN.
참고문헌 (22)
- Aho M, "Natural history of vaginal intraepithelial neoplasia", Cancer, 68, pp.195~197 (1991)
- Ashiuchi M, "Isolation of Bacillus subtilis (chungkookjang), a polygamma-glutamate producer with high genetic competence", Appl. Microbiol. Biotechnol, 57, pp.764~769 (2001)
- Audet-Lapointe P, "Vaginal intraepithelial neoplasia", Gynecol. Oncol, 36, pp.232~239 (1990)
- Bajaj I, "Poly (glutamic acid) - an emerging biopolymer of commercial interest", Bioresour. Technol, 102, pp.5551~5561 (2011)
- De Vuyst H, "Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis", Int. J. Cancer, 124, pp.1626~1236 (2009)
- Frega A, "Prediction of persistent vaginal intraepithelial neoplasia in previously hysterectomized women by high-risk HPV DNA detection", Cancer Lett, 249, pp.235~241 (2007)
- Gunderson CC, "A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia", Am. J. Obstet. Gynecol, 208, pp.410.e1-e6~ (2013)
- Gurumurthy M, "Management of vaginal intraepithelial neoplasia", J. Low Genit. Tract Dis, 16, pp.306~312 (2012)
- Henson D, "An epidemiologic study of cancer of the cervix, vagina, and vulva based on the Third National Cancer Survey in the United States", Am. J. Obstet. Gynecol, 129, pp.525~532 (1977)
- Insing a RP, "A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States", Cancer Epidemiol. Biomarkers Prev, 17, pp.1611~1622 (2008)
- Kim TW, "Oral administration of high molecular mass polygamma-glutamate induces NK cell-mediated antitumor immunity", J. Immunol, 179, pp.775~780 (2007)
- 구천회, "Effect of human papillomavirus genotype on severity and prognosis of cervical intraepithelial neoplasia", Obstetrics & Gynecology Science, 57(01), pp.37~43 (2014), 대한산부인과학회[DOI]
- Lee TY, "Oral administration of poly-gamma-glutamate induces TLR4- and dendritic cell-dependent antitumor effect", Cancer Immunol. Immunother, 58, pp.1781~1794 (2009)
- Li H, "Risk factors for the development of vaginal intraepithelial neoplasia", Chin. Med. J, 125, pp.1219~1223 (2012)
- Oppermann-Sanio FB, "Occurrence, functions and biosynthesis of polyamides in microorganisms and biotechnological production", Naturwissenschaften, 89, pp.11~22 (2002)
- Rome RM, "Management of vaginal intraepithelial neoplasia: a series of 132 cases with longterm follow-up", Int. J. Gynecol. Cancer, 10, pp.382~390 (2000)
- Schockaert S, "Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study", Am. J. Obstet. Gynecol, 199, pp.113.e1-e5~ (2008)
- Sillman FH, "Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion and its management", Am. J. Obstet. Gynecol, 176, pp.93~99 (1997)
- Smith JS, "Human papillomavirus type distribution in vulvar and vaginal cancers and their associated precursors", Obstet. Gynecol, 113, pp.917~924 (2009)
- 송진호, "High-Dose-Rate Brachytherapy for the Treatment of Vaginal Intraepithelial Neoplasia", Cancer Research and Treatment, 46(1), pp.74~80 (2014), 대한암학회
- Sung MH, "Natural and edible biopolymer poly-gamma-glutamic acid: synthesis, production, and applications", Chem. Rec, 5, pp.352~366 (2005)
- Zeligs KP, "A clinicopathologic study of vaginal intraepithelial neoplasia", Obstet. Gynecol, 122, pp.1223~1230 (2013)